Literature DB >> 5666109

Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.

J F Bertles, P F Milner.   

Abstract

THE AMOUNT OF FETAL HEMOGLOBIN (HB F) IN ERYTHROCYTES OF PATIENTS WITH SICKLE CELL ANEMIA (HB SS DISEASE) WAS MEASURED BY TWO
METHODS: (a) photometry of individual cells stained for Hb F by the Kleihauer-Betke technique; and (b) chemical assay of alkali-resistant hemoglobin in cells distributed according to specific gravity by ultracentrifugation. Irreversibly sickled cells (ISC), which could be identified directly during photometry and which were found to gather in high concentration at the bottom of ultracentrifuged cell columns, contained significantly less Hb F than non-ISC. Cell content of total Hb was constant regardless of cell size, shape, or ultracentrifugal behavior: thus absolute amounts of Hb F and S varied reciprocally from cell to cell. In experiments designed to estimate age, at formation, and rate of destruction of ISC, Hb SS blood was incubated with selenomethionine-(75)Se (which labels reticulocytes) or (51)Cr (which labels erythrocytes at random) and reinfused. Sequential blood samples were separated by ultracentrifugation into fractions rich in reticulocytes, non-ISC, and ISC; and chronological changes in the specific activity of each fraction were determined. Analogous information was obtained from radioautography of sequential blood samples after reinfusion of whole blood labeled with amino acids-(3)H: this technique permitted direct visual characterization of labeled erythrocytes as ISC or non-ISC, all of which had been reticulocytes at the time of reinfusion. The transformation of non-ISC into ISC, presumably a manifestation of membrane damage, proved to begin soon after cell release from the marrow; and ISC subsequently underwent rapid removal from the circulating blood. IT IS THEREFORE APPARENT FROM THESE STUDIES THAT, IN HB SS DISEASE, RELATIVELY SMALL RECIPROCAL CHANGES IN THE AMOUNTS OF THE TWO MAJOR HEMOGLOBINS CARRY PREDICTIVE IMPORTANCE: (a) net synthesis of Hb F is least in erythroid cells destined to become ISC; and (b) these irreversibly deformed erythrocytes suffer preferential destruction.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5666109      PMCID: PMC297333          DOI: 10.1172/JCI105863

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  [Demonstration of fetal hemoglobin in erythrocytes of a blood smear].

Authors:  E KLEIHAUER; H BRAUN; K BETKE
Journal:  Klin Wochenschr       Date:  1957-06-15

2.  The crisis in sickle cell anemia; hematologic studies.

Authors:  L W DIGGS
Journal:  Am J Clin Pathol       Date:  1956-10       Impact factor: 2.493

3.  Observations on the sickling phenomenon and on the distribution of different haemoglobin types in erythrocyte populations.

Authors:  A C ALLISON
Journal:  Clin Sci       Date:  1956-11       Impact factor: 6.124

4.  The hematocrit of capillary blood.

Authors:  J J McGOVERN; A R JONES; A G STEINBERG
Journal:  N Engl J Med       Date:  1955-08-25       Impact factor: 91.245

5.  Standardizing a method for clinical hemoglobinometry.

Authors:  W H CROSBY; J I MUNN; F W FURTH
Journal:  U S Armed Forces Med J       Date:  1954-05

6.  Solubilities of naturally occurring mixtures of human hemoglobin.

Authors:  H A ITANO
Journal:  Arch Biochem Biophys       Date:  1953-11       Impact factor: 4.013

7.  Studies on abnormal hemoglobins. V. The distribution of type S, sickle cell, hemoglobin and type F, alkali resistant, hemoglobin within the red cell population in sickle cell anemia.

Authors:  K SINGER; B FISHER
Journal:  Blood       Date:  1952-12       Impact factor: 22.113

8.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

9.  Se75-selenomethionine incorporation into human plasma proteins and erythrocytes.

Authors:  H K Qawwad; E J Potchen; S J Adelstein; J B Dealy
Journal:  Metabolism       Date:  1966-07       Impact factor: 8.694

10.  The physical state of hemoglobin in sickle-cell anemia erythrocytes in vivo.

Authors:  J Döbler; J F Bertles
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

View more
  49 in total

1.  Fetal haemoglobin and early manifestations of homozygous sickle cell disease.

Authors:  K Bailey; J S Morris; P Thomas; G R Serjeant
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Intermolecular interactions of oxygenated sickle hemoglobin molecules in cells and cell-free solutions.

Authors:  T R Lindstrom; S H Koenig; T Boussios; J F Bertles
Journal:  Biophys J       Date:  1976-06       Impact factor: 4.033

3.  Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

Authors:  L De Franceschi; D Bachir; F Galacteros; G Tchernia; T Cynober; S Alper; O Platt; Y Beuzard; C Brugnara
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes.

Authors:  C H Joiner; O S Platt; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

5.  A mathematical model of the volume, pH, and ion content regulation in reticulocytes. Application to the pathophysiology of sickle cell dehydration.

Authors:  V L Lew; C J Freeman; O E Ortiz; R M Bookchin
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 6.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

7.  Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells.

Authors:  R S Franco; J Lohmann; E B Silberstein; G Mayfield-Pratt; M Palascak; T A Nemeth; C H Joiner; M Weiner; D L Rucknagel
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  Measuring single-cell density.

Authors:  William H Grover; Andrea K Bryan; Monica Diez-Silva; Subra Suresh; John M Higgins; Scott R Manalis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

9.  Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.

Authors:  D A Deiderich; R C Trueworthy; P Gill; A M Cader; W E Larsen
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

10.  Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.

Authors:  S E Lux; K M John; M J Karnovsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.